Ohio’s Hospice CEO: Prepare for Value-Based Care

Why It Matters

The shift to value‑based reimbursement will reshape hospice financing, forcing providers to leverage scale and technology to maintain quality while controlling costs.

Key Takeaways

• Ohio's Hospice unites eight nonprofit providers for collective bargaining power
• Scale enables shared logistics, covering nearly 1 million visits and 7 million miles
• CEO aims to use AI to cut clinicians' documentation workload
• U.S. deaths projected at 4 million by 2060, boosting hospice demand
• Value‑based care seen as remedy for fragmented, unsustainable health system

Pulse Analysis

The hospice industry is at a crossroads as payers pivot toward value‑based models that reward outcomes over volume. Unlike acute care, hospice has traditionally operated on per‑diem rates, but rising mortality projections—estimated at four million deaths annually by 2060—are prompting insurers to explore risk‑adjusted payments that align incentives with quality and cost efficiency. This transition mirrors broader health‑care reforms aimed at curbing fragmentation, reducing unnecessary utilization, and improving patient‑centered care across the continuum.

Ohio’s Hospice illustrates how regional collaboration can mitigate the challenges of this shift. By aggregating eight nonprofit providers, the network achieves bargaining power with vendors and payers, while sharing back‑office functions that support nearly one million patient visits and seven million miles of travel each year. The alliance’s focus on equitable access—tailoring services to patients’ acuity and caregiver capacity—demonstrates a nuanced approach to value‑based care that goes beyond blanket cost cuts. Additionally, the cautious integration of artificial intelligence seeks to streamline documentation, freeing clinicians to deliver high‑touch care without sacrificing efficiency.

For the broader market, the Ohio model signals that scale, data‑driven operations, and mission‑centric strategies will be essential to thrive under value‑based contracts. Providers that can demonstrate measurable outcomes, manage staffing shortages, and navigate regulatory complexities will attract partnerships with health systems seeking reliable hospice partners. Conversely, private‑equity entrants may face heightened scrutiny as payers demand transparent performance metrics. Ultimately, hospices that blend technological innovation with the core compassion of end‑of‑life care will be best positioned to secure sustainable reimbursement and maintain relevance in a rapidly evolving health‑care landscape.